Cottage Street Advisors LLC Bristol Myers Squibb CO Transaction History

Cottage Street Advisors LLC

$192 Billion
Q4 2024

A detailed history of Cottage Street Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cottage Street Advisors LLC holds 8,259 shares of BMY stock, worth $462,256. This represents 0.24% of its overall portfolio holdings.

Number of Shares

8,259

Previous 8,357 1.17%

Holding current value

$462,256

Previous $432 Million 8.02%

% of portfolio

0.24%

Previous 0.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$51.92 - $59.94 $5,088 - $5,874	-98 Reduced 1.17%	8,259 $467 Million
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $277 - $362	7 Added 0.08%	8,357 $432 Million
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $12,719 - $16,744	-316 Reduced 3.65%	8,350 $347 Million
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $4,462 - $5,059	-93 Reduced 1.06%	8,666 $470 Million
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $14,204 - $16,950	-293 Reduced 3.24%	8,759 $454 Million
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $289 - $323	5 Added 0.06%	9,052 $525 Million
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $318 - $353	5 Added 0.06%	9,047 $579 Million
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $594,149 - $673,900	9,042 New	9,042 $627 Million
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $0 - $230	3 Added 0.03%	8,983 $639,000
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $2,614 - $2,879	36 Added 0.4%	8,980 $691,000
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $245 - $294	4 Added 0.04%	8,944 $653,000
Q4 2021 Jan 13, 2022	SELL	$53.63 - $62.52 $7,561 - $8,815	-141 Reduced 1.55%	8,940 $557,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $6,094 - $7,138	103 Added 1.15%	9,081 $542,000
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $2,290 - $2,494	37 Added 0.41%	8,978 $600,000
Q1 2021 Apr 22, 2021	BUY	$59.34 - $66.74 $6,468 - $7,274	109 Added 1.23%	8,941 $564,000
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $28,812 - $32,649	-499 Reduced 5.35%	8,832 $548,000
Q3 2020 Oct 08, 2020	BUY	$57.43 - $63.64 $10,050 - $11,137	175 Added 1.91%	9,331 $563,000
Q2 2020 Jul 09, 2020	SELL	$54.82 - $64.09 $27,410 - $32,045	-500 Reduced 5.18%	9,156 $538,000
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $23,200 - $33,715	500 Added 5.46%	9,656 $538,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $1,623 - $2,118	33 Added 0.36%	9,156 $588,000
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $175,445 - $194,004	-3,932 Reduced 30.12%	9,123 $414,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $45,120 - $53,800	-1,000 Reduced 7.11%	13,055 $623,000
Q4 2018 Feb 01, 2019	BUY	$48.76 - $63.23 $48,760 - $63,230	1,000 Added 7.66%	14,055 $731,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $5,053 - $6,298	-100 Reduced 0.76%	13,055 $721,000
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $46,078 - $53,045	-769 Reduced 5.52%	13,155 $831,000
Q4 2017 Jan 16, 2018	SELL	$59.94 - $65.35 $75,884 - $82,733	-1,266 Reduced 8.33%	13,924 $854,000
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $838,943 - $968,210	15,190	15,190 $969,000

Others Institutions Holding BMY

# of Institutions

2,706

Shares Held

1.54B

Call Options Held

32M

Put Options Held

34.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cottage Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cottage Street Advisors LLC with notifications on news.

Account

Cottage Street Advisors LLC Bristol Myers Squibb CO Transaction History